1. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. (8th May 2017) Authors: Bamias, A.; Gibbs, E.; Khoon Lee, C.; Davies, L.; Dimopoulos, M.; Zagouri, F.; Veillard, A.-S.; Kosse, J.; Santaballa, A.; Mirza, M. R.; Tabaro, G.; Vergote, I.; Bloemendal, H.; Lykka, M.; Floquet, A.; Gebski, V.; Pujade-Lauraine, E. Journal: Annals of oncology Issue: Volume 28:Number 8(2017) Page Start: 1842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0145: Preoperative radiotherapy with an integrated boost compared to chemoradiotherapy for rectal cancer. (April 2016) Authors: De Ridder, M.; De Paoli, A.; Delmastro, E.; Munoz, F.; Vagge, S.; Norkus, D.; Everaert, H.; Tabaro, G.; Garibaldi, E.; Ricardi, U.; Borsatti, E.; Gevaert, T.; Gabriele, P.; Boz, G.; Sermeus, A.; Mahé, M.A.; Engels, B. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗